Showing results (91-100 of 176) with videos related to
Sort By:
Pageof 18
The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.International Journal of Cardiology|May 4, 2016
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approvalFaiez Zannad, Patrick Rossignol, Wendy Gattis Stough, et al.JAMA|April 24, 2003
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialHenry R Black, William J Elliott, Gregory Grandits, et al.Circulation|April 2, 2008
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysisScott D Solomon, Janet Wittes, Peter V Finn, et al.Genetic Testing|September 7, 2002
Pre-counseling education materials for BRCA testing: does tailoring make a difference?Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, et al.Cardiology in the Young|March 5, 2010
Do neonates, infants and young children need a higher dose of enoxaparin in the cardiac intensive care unit?Joan Sanchez de Toledo, Sriya Gunawardena, Ricardo Munoz, et al.The Journal of Pediatrics|May 2, 2006
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Roberto Giugliani, Ida Schwartz, et al.Journal of Hypertension|April 19, 2005
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical regionHenry R Black, William J Elliott, Gregory Grandits, et al.Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE TrialHenry R. Black, William J. Elliott, James D. Neaton, et al.Pageof 18